Shares of Healthequity Inc (NASDAQ:HQY) have been assigned a consensus recommendation of “Buy” from the fifteen research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $90.15.
A number of analysts recently issued reports on the stock. BidaskClub upgraded shares of Healthequity from a “buy” rating to a “strong-buy” rating in a research note on Thursday, November 1st. Cantor Fitzgerald lifted their price target on shares of Healthequity from $80.00 to $82.00 and gave the stock a “neutral” rating in a research note on Thursday, December 6th. SunTrust Banks lowered shares of Healthequity from a “buy” rating to a “hold” rating and dropped their price target for the stock from $105.00 to $90.00 in a research note on Thursday, December 6th. ValuEngine lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, December 5th. Finally, Zacks Investment Research lowered shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Tuesday, November 20th.
In other Healthequity news, Director Frank Corvino sold 1,778 shares of the business’s stock in a transaction on Monday, December 10th. The shares were sold at an average price of $67.78, for a total transaction of $120,512.84. Following the completion of the sale, the director now owns 5,051 shares in the company, valued at $342,356.78. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction on Thursday, December 20th. The shares were sold at an average price of $60.28, for a total transaction of $241,120.00. Following the sale, the vice president now owns 82,000 shares of the company’s stock, valued at approximately $4,942,960. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,846 shares of company stock valued at $1,163,748. 4.00% of the stock is owned by insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. Advisors Asset Management Inc. lifted its holdings in Healthequity by 57.4% in the second quarter. Advisors Asset Management Inc. now owns 2,136 shares of the company’s stock worth $160,000 after purchasing an additional 779 shares during the period. Meeder Asset Management Inc. acquired a new stake in Healthequity in the third quarter worth about $172,000. Cerebellum GP LLC acquired a new stake in Healthequity in the third quarter worth about $185,000. Cambridge Investment Research Advisors Inc. acquired a new stake in Healthequity in the third quarter worth about $210,000. Finally, CIBC Asset Management Inc acquired a new stake in Healthequity in the third quarter worth about $214,000. 92.31% of the stock is owned by institutional investors.
Shares of HQY traded down $1.45 during mid-day trading on Tuesday, reaching $54.58. 239,982 shares of the stock traded hands, compared to its average volume of 966,608. The firm has a market capitalization of $3.36 billion, a P/E ratio of 101.07, a P/E/G ratio of 2.06 and a beta of 1.78. Healthequity has a 12-month low of $47.23 and a 12-month high of $101.58.
Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, December 4th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. The business had revenue of $70.50 million during the quarter, compared to analyst estimates of $69.60 million. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The business’s revenue was up 24.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.17 earnings per share. As a group, analysts forecast that Healthequity will post 0.88 earnings per share for the current year.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also: Debt-To-Equity Ratio
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.